EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Yanfang Xia iD, Jelena Wehrli, Aslan Abivardi iD, Madalina Hostiuc, Birgit Kleim, Dominik R Bach

Translational Psychiatry · 17.01.2024 · 14 (1)

DOI: 10.1038/s41398-024-02732-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Translational Psychiatry, online erschienen am 17.01.2024. Verfasst von Yanfang Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Computational Psychiatry Research, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of …. Hauptthemen laut MEDLINE: Minocycline, Matrix Metalloproteinase 9. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pavlovian fear conditioning is widely used as a pre-clinical model to investigate methods for prevention and treatment of anxiety and stress-related disorders. In this model, fear memory consolidation is thought to require synaptic remodeling, which is induced by signaling cascades involving matrix metalloproteinase 9 (MMP-9). Here we investigated the effect of the tetracycline antibiotic minocycline, an inhibitor of MMP-9, on fear memory retention. We conducted a pre-registered, randomized, double-blind, placebo-controlled trial in N = 105 healthy humans ( N = 70 female), using a configural fear conditioning paradigm. We administered a single dose of minocycline before configural fear memory acquisition and assessed fear memory retention seven days later in a recall test. To index memory retention, we pre-registered fear-potentiated startle (FPS) as our primary outcome, and pupil dilation as the secondary outcome. As control indices of memory acquisition, we analyzed skin conductance responses (SCR) and pupil dilation. We observed attenuated retention of configural fear memory in individuals treated with minocycline compared to placebo, as measured by our primary outcome. In contrast, minocycline did not affect fear memory acquisition or declarative contingency memory. Our findings provide in-vivo evidence for the inhibition of fear memory consolidation by minocycline. This could motivate further research into primary prevention, and given the short uptake time of minocycline, potentially also secondary prevention of PTSD after trauma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MinocyclineMatrix Metalloproteinase 9HumansFemaleMemoryFearMental RecallExtinction, PsychologicalReflex, Startle

Substanzen

MinocyclineMatrix Metalloproteinase 9

Autor:innen und Institutionen

  • Computational Psychiatry Research, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. yanfang.xia@donders.ru.nl.
  • Transdisciplinary Research Area Life and Health, Hertz Chair for Artificial Intelligence and Neuroscience, University of Bonn, Bonn, Germany. yanfang.xia@donders.ru.nl.
  • Computational Psychiatry Research, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Computational Psychiatry Research, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. d.bach@uni-bonn.de.
  • Transdisciplinary Research Area Life and Health, Hertz Chair for Artificial Intelligence and Neuroscience, University of Bonn, Bonn, Germany. d.bach@uni-bonn.de.

ORCID-Profile: Yanfang Xia, Aslan Abivardi

Förderung

  • European Research Council

Zitieren

APA

Xia, Y., Wehrli, J., Abivardi, A., Hostiuc, M., Kleim, B., & Bach, D. R. (2024). Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial. Translational Psychiatry, 14(1). https://doi.org/10.1038/s41398-024-02732-2

Vancouver

Xia Y, Wehrli J, Abivardi A, Hostiuc M, Kleim B, Bach DR. Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial. Translational Psychiatry. 2024;14(1). doi:10.1038/s41398-024-02732-2

BibTeX
@article{Xia2024,
  author = {Xia, Yanfang and Wehrli, Jelena and Abivardi, Aslan and Hostiuc, Madalina and Kleim, Birgit and Bach, Dominik R},
  title = {Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial},
  journal = {Translational Psychiatry},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1038/s41398-024-02732-2}
}
Kostenlos starten →